What Quantify Research does

Quantify Research is a privately held health economics and outcomes research (HEOR) consultancy founded in 2011 in Stockholm, Sweden, now operating as part of the Athagoras Group. The company delivers health economic modelling, real-world evidence generation, market access strategy, evidence review and synthesis, and medical writing services to large pharmaceutical companies, medical device manufacturers, government bodies, and academic institutions across Europe and North America. Its core differentiator is access to Nordic administrative and disease-specific registries providing population-level coverage of approximately 26 million inhabitants across Sweden, Denmark, Norway, and Finland, with the ability to link patient-level data across primary care, hospitalizations, prescriptions, socioeconomics, labs, EHRs, and PROMs. Quantify maintains disease-specific research platforms in asthma (NORDSTAR, covering 3 million+ patients), cardiovascular disease, chronic liver disease (HERALD, with Karolinska Institutet), Parkinson's disease, psoriasis/psoriatic arthritis, and oncology.

Quantify Research operates a portfolio of proprietary software tools built on top of this data and consulting expertise. These include Qniform (a proprietary common data model for cross-Nordic data harmonization and validation), Q-tracker (a Power BI-based interactive visualization and analysis tool), Qfront (a cloud-based web application platform that converts Excel-based health economic models into interactive multi-user web apps), Qmodel (a free, generic Excel-based cost-effectiveness model for oncology), and Quantify Data Explorer (an R Shiny-based epidemiological visualization tool). The company combines 50% PhD-level talent with active academic affiliations to Karolinska Institutet, holds a track record of 200+ completed observational data projects and 100+ peer-reviewed publications, and reports data access turnarounds as short as two weeks.

The business model is professional services revenue generated through quote-based B2B engagements, augmented by productized software and disease-specific data platforms that support reuse across pharma accounts. Quantify operates from offices in Stockholm (headquarters), Copenhagen, Helsinki, Oslo, and Chandigarh (via wholly-owned subsidiary Quantify HEOR Private Limited), with a 11-50 employee base. Distribution is primarily enterprise direct sales supplemented by scientific-community marketing through ISPOR, EASL, EHA, Eurospine, and similar conferences, alongside an active peer-reviewed publication program that drives inbound enterprise interest. No external funding rounds are disclosed.

Name

Quantify Research

Legal name

Quantify Research AB

Website

https://quantifyresearch.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Quantify Research is a Stockholm-based HEOR consultancy providing health economic modelling, real-world evidence, and market access services to pharmaceutical, medical device, government, and academic clients, leveraging proprietary access to Nordic registry data covering ~26 million inhabitants and a portfolio of in-house analytics software tools.

Ownership category

akta.pro rank

Product category

Health Economics & Outcomes Research Consulting

NAICS

Other Scientific and Technical Consulting Services (54169), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

akta.pro secondary industries

Data Linkage, Registries & Longitudinal Cohort Surveillance (HLAJANAM), Healthcare Data Quality, Profiling & Observability (HLACAIAE), Quality Measurement, Reporting & Benchmarking (HEDIS/Stars/CQM) (HLACAHAC)

Keywords

• Health economics consulting
• Real-world evidence
• Market access services
• Outcomes research
• Pharmaceutical analytics

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Health Economics & Outcomes Research Consultancy: Professional services revenue generated through consulting engagements with pharmaceutical companies, biotech firms, healthcare organizations, and government bodies. Services include economic modelling, evidence generation, market access strategy, and biostatistics analysis.
2. Real-World Evidence Studies: RWE generation services using Nordic registry data for clinical, economic, and regulatory decision-making purposes across product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Quantify Research is a health economics and outcomes research consultancy that delivers health economic modelling, Nordic market access strategy, real-world evidence generation from Nordic registries, evidence review and synthesis, and medical writing for pharmaceutical, biotech, medical device, and government clients. The firm complements its consulting services with proprietary software (Qniform, Q-tracker, Qfront, Qmodel, Quantify Data Explorer) and disease-specific real-world data platforms covering asthma, cardiovascular disease, chronic liver disease, Parkinson's disease, psoriasis, and oncology.

Product overview

Quantify Research offers a portfolio of software tools and research platforms that complement its consulting services in health economics, outcomes research, real-world evidence (RWE), and market access. The core technology products include: Q-tracker (Power BI-based interactive visualization), Qfront (cloud-based web application platform connecting Excel-based economic models to web apps), Qmodel (free generic Excel-based oncology cost-effectiveness model), Qniform (proprietary common data model for cross-Nordic RWE data harmonization), and Quantify Data Explorer (R Shiny-based epidemiological data visualization tool). The company also maintains disease-specific RWD platforms for asthma (NORDSTAR), cardiovascular disease, chronic liver disease (HERALD), Parkinson's disease (Q-PARK), and psoriasis/psoriatic arthritis (Q-PsO/Q-PsA), along with a full suite of service offerings covering economic modelling, market access strategy, evidence review and synthesis, medical writing, and medical device support.

Differentiator

Problem solved

Functional benefit

Products and services

• Modelling, Access & Strategy
• Real-World Evidence & Analytics
• Evidence Review & Synthesis
• Medical Writing and Editorial Support
• Medical Devices (MedTech & Digital Health)
• Q-tracker
• Qfront
• Qmodel
• Qniform
• Quantify Data Explorer
• NORDSTAR (Nordic Dataset for Asthma Research)
• Cardiovascular Disease Research Platform
• HERALD (HEalth outcomes and Risk Assessment in chronic Liver Disease)
• Q-PARK (Quantify Parkinson's Research Programme)
• Q-PsO and Q-PsA (Psoriasis and Psoriatic Arthritis Platforms)
• Oncology Research Platform (Solid Tumor & Hematologic)

Quantifiable outcome

• 200+ observational data projects completed
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Partnerships

Six partnerships are on record, tiered minor and core.

• IFPA (International Federation of Psoriasis Associations)minorStrategic or Co-development Partner · 1 January 2026Partnership on publication 'Economic Impact of Timely Systemic Treatment of Psoriatic Disease in Comorbidity Risk Reduction' published in Dermatology and Therapy.
• HERALD (Karolinska University Hospital and Karolinska Institutet)coreStrategic or Co-development Partner · 1 January 2021Swedish collaborative research programme on chronic liver disease including several data sources linked on patient level. Led by Oskar Ström and Emilie Toresson Grip. Planned to generate quality research between 2021-2026.
• NORDSTAR (Nordic Dataset for Asthma Research)coreStrategic or Co-development PartnerCross-border multi-party collaboration between Nordic clinical asthma experts, Quantify Research, and pharmaceutical industry. Aims to improve understanding of burden of severe asthma and potential for improving patient prognosis. Currently comprises 3+ million asthma patients across Finland, Denmark, Norway, and Sweden.
• IMI ROADMAPminorStrategic or Co-development PartnerProject designed to provide a foundation for an integrated data environment and framework for real-world evidence research within Alzheimer's disease.
• International Osteoporosis Foundation (IOF)minorStrategic or Co-development PartnerGlobal alliance of patient societies, research organizations, healthcare professionals and international companies working to promote bone, muscle and joint health.
• IPECADminorStrategic or Co-development PartnerForum for the value demonstration of Alzheimer interventions. Anders Gustavsson from Quantify sits in the steering committee and has co-developed an open-source cost-effectiveness model for AD.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• ICON plc: Global CRO with substantial real-world evidence and HEOR capabilities following the PRA Health Sciences acquisition. Competes with Quantify for biopharma outcomes research and market access work, but at meaningfully greater scale.
• IQVIA: Largest global CRO and life sciences data services provider with broad HEOR, RWE, and market access practices. Competes with Quantify for pharma HEOR mandates but offers a much wider service portfolio and global delivery footprint.
• Parexel International: Major global CRO with HEOR and real-world evidence capabilities. Quantify's CEO Kirk Geale previously held an HEOR role at Parexel, reflecting the talent pipeline overlap and the direct competition for pharma HEOR/RWE engagements.
• Optum Insight: Health services, data, and consulting arm of UnitedHealth Group with significant real-world evidence and HEOR capabilities. Competes with Quantify for pharma evidence-generation work and benefits from very large US claims/EHR data assets.

Emerging players

• Aetion: Tech-led RWE analytics company used by pharma and regulators for evidence generation. Competes with Quantify for RWE mandates, particularly those requiring analytics-platform-driven approaches, but lacks the Nordic registry depth that Quantify offers.
• Flatiron Health: Roche-owned oncology-focused real-world data and evidence company. Overlaps with Quantify's Oncology Research Platform work, particularly on cancer epidemiology and outcomes, though Flatiron's data depth is concentrated in US oncology EHR sources rather than Nordic registries.

Direct peers

• RTI Health Solutions: HEOR, real-world evidence, and patient-centered outcomes consultancy within RTI International. Comparable in service offering — economic modelling, systematic reviews, RWE for pharma and medical devices — but with a broader therapeutic and geographic footprint.
• Cytel: Statistical and HEOR consulting firm with biostatistics, real-world evidence, and market access offerings to pharma. Comparable to Quantify in the biostatistics and evidence-generation layer, with somewhat larger scale and broader therapeutic coverage.
• Evidera: Pure-play HEOR, real-world evidence, and market access consulting firm (owned by PPD, part of Thermo Fisher). Most directly comparable to Quantify in terms of service mix — economic modelling, RWE, evidence synthesis — but operates at significantly greater global scale.
• BresMed: HEOR and market access consultancy serving pharma clients (Puneet Kaushik, Quantify's India Country Director, previously worked at BresMed). Very close comparable in team size, service mix (economic modelling, evidence review), and pharma-segment focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/QuantifyRes
• Facebookfacebook.com/QuantifyRes
• LinkedInlinkedin.com/company/quantify-research

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quantify Research